会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明公开
    • 양수 내 태아 유래 중간엽줄기세포를 이용한 성장인자의 대량생산 방법
    • 使用来自生物体液体的衍生的间充质干细胞生长促进因子的大规模生产
    • KR1020100105165A
    • 2010-09-29
    • KR1020090024054
    • 2009-03-20
    • 주식회사 스템메디언스
    • 유승권윤병선전은경문재희김종건정혜연이중한박을순맹이삭김준성이장호이황희이종원조경식
    • C12N5/071C12N5/02
    • C12N5/0605C12N5/0668C12N2501/115
    • PURPOSE: A mesenchymal stem cell derived from fetus in amniotic fluid by culturing is provided to ensure pluripotency and to massively produce growth factors. CONSTITUTION: A mesenchymal stem cell derived from fetus in amniotic fluid is prepared by culturing the fetus-derived cells in a medium containing 10% of FBS(fetal bovaine seru) and 1-20 ng/ml of bFGF(basic fibroblast growth factor). The medium is low glucose DMEM(Dulbecco's Modified Eagle's Medium) medium. The mesoderm-derived cell is adipocyte, osteocyte, or chondrocyte. A method for massively producing the human growth factor from mesenchymal stem cell comprises: a step of isolating fetus-derived cell from a lying-in women; a step of sub-culturing in a medium containing FBS and bFGF to obtain mesenchymal stem cells; and a step of culturing the mesenchymal stem cell in serum free medium for 2-7 days to prepare a conditioned medium.
    • 目的:提供通过培养从羊水中产生的间充质干细胞,以确保多能性并大量产生生长因子。 构成:通过在含有10%FBS(胎牛血清)和1-20ng / ml bFGF(碱性成纤维细胞生长因子)的培养基中培养来自胎儿的细胞来制备源自羊水中的胎儿的间充质干细胞。 培养基为低糖DMEM(Dulbecco's Modified Eagle's Medium)培养基。 中胚层衍生的细胞是脂肪细胞,骨细胞或软骨细胞。 从间充质干细胞大规模生产人生长因子的方法包括:从躺卧妇女中分离胎儿来源的细胞的步骤; 在含有FBS和bFGF的培养基中亚培养以获得间充质干细胞的步骤; 以及在无血清培养基中培养间充质干细胞2-7天以制备条件培养基的步骤。